Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status (original) (raw)
Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases
Hayrettin Tumani
Expert Review of Molecular Diagnostics, 2008
View PDFchevron_right
Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up
Radoslav Matěj
Scientific Reports, 2021
View PDFchevron_right
Cerebrospinal fluid biomarkers in neurodegenerative disorders
Peter Panegyres
Future Neurology, 2019
View PDFchevron_right
The importance of harmonizing and standardizing CNS biomarkers of neurodegeneration
Mauro Fasano
Future Neurology, 2012
View PDFchevron_right
Relevance of biomarkers across different neurodegenerative diseases
Konstantin Senkevich
Alzheimer's Research & Therapy
View PDFchevron_right
A Prospective Viewpoint on Neurological Diseases and Their Biomarkers
Mahrukh Zehravi
Molecules
View PDFchevron_right
Upcoming diagnostic biomarkers with promising prospects in neurological disorders
Dr. Ibraheem husain
Clinical and Experimental Pharmacology and Physiology
View PDFchevron_right
Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive Impairment
Joshua Sonnen
Current Neurology and Neuroscience Reports, 2011
View PDFchevron_right
Mechanism and biomarkers for neurodegenerative diseases: A systematic review
IP Innovative Publication Pvt. Ltd.
IP innovative publication pvt ltd, 2020
View PDFchevron_right
Quantification of neurodegeneration by measurement of brain-specific proteins
Gavin Giovannoni
Journal of Neuroimmunology, 2003
View PDFchevron_right
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Magdalena Korecka
Nature Reviews Drug Discovery, 2007
View PDFchevron_right
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Brian Gordon
View PDFchevron_right
Molecular biomarkers of neurodegeneration
Hugh Salter
Expert Review of Molecular Diagnostics, 2013
View PDFchevron_right
Quest for new genomic and proteomic biomarkers in neurology
Kristina Gotovac
Translational Neuroscience, 2011
View PDFchevron_right
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
Konstantin Senkevich
Alzheimer's Research & Therapy
View PDFchevron_right
cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
Hans-wolfgang Klafki
International Journal of Alzheimer's Disease, 2010
View PDFchevron_right
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
Hayrettin Tumani
Journal of Neurology, 2011
View PDFchevron_right
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
alessandra della vecchia
Expert Review of Molecular Diagnostics, 2020
View PDFchevron_right
Biomarkers for Alzheimer’s disease and other forms of dementia: Clinical needs, limitations and future aspects
Bengt Winblad
Experimental Gerontology, 2010
View PDFchevron_right
A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases
stephan breimann
eBioMedicine
View PDFchevron_right
The Analytical Aspects and Regulatory Challenges of Biomarker Discovery: Examples from the Field of Neurodegeneration
Arron Xu
Current Translational Geriatrics and Experimental Gerontology Reports, 2012
View PDFchevron_right
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis
Kunal Dhiman
Cellular and Molecular Life Sciences
View PDFchevron_right
Interpretation of cerebrospinal fluid protein assays in various neurologic diseases
James F Howard Jr
Clinical chemistry, 1983
View PDFchevron_right
Neuroproteomics: Advancement and challenges for biomarker discovery in neurodegenerative diseases
hisamuddin malik
International Journal of Pharmacy and Pharmaceutical Sciences, 2013
View PDFchevron_right
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Sebastiaan Engelborghs
Alzheimer's research & therapy, 2018
View PDFchevron_right
Editorial: biomarkers in neurology
Stefania Mondello
2020
View PDFchevron_right
Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases
Magdalena Smetakova
BMC Neurology, 2015
View PDFchevron_right
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
Dubravka Švob Štrac
Croatian Medical Journal, 2014
View PDFchevron_right